D.C. Appeals Court OKs "Authorized Generics"

Law360, New York (June 7, 2005, 12:00 AM EDT) -- In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court has ruled that brand-name drug companies have the right to sell unbranded versions of their own drugs even if they undercut sales of generic competitors.

In a decision reached on Friday of last week, the U.S. Court of Appeals for the District of Columbia said the law doesn't prohibit drug companies from launching "authorized generics."

The decision marked a setback for Israeli generic maker Teva Pharmaceutical Industries Ltd., which had sued the...
To view the full article, register now.